Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Authors:
Open Access
- 14 August 2023
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 4 (9) , 101173
Abstract
No abstract availableKeywords
Funding Information
- Government of South Australia
- Clinical and Translational Science Institute, Boston University (TL1TR001447)
- National Cancer Institute (U24CA210972)
- National Institute of Environmental Health Sciences (75N91019D00024, 75N91020F00029, P30ES017885)
- National Center for Advancing Translational Sciences (F30CA271622)
- National Institutes of Health (S21-167, U01CA214114, U01CA214116, U01CA214125, U24CA210954, U24CA210955, U24CA210967, U24CA210979, U24CA210985, U24CA210986, U24CA210993)
- U.S. Department of Health and Human Services
This publication has 34 references indexed in Scilit:
- Digital pathology and artificial intelligenceThe Lancet Oncology, 2019
- Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learningNature Medicine, 2018
- Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data SharingCell, 2018
- Oncogenic Signaling Pathways in The Cancer Genome AtlasCell, 2018
- A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 ProfilesCell, 2017
- Rethinking the Inception Architecture for Computer Vision2016
- Structure-Preserving Color Normalization and Sparse Stain Separation for Histological ImagesIEEE Transactions on Medical Imaging, 2016
- The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information RepositoryJournal of Digital Imaging, 2013
- A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysisBiostatistics, 2009
- Proteomics Technologies and ChallengesGenomics, Proteomics & Bioinformatics, 2007